Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation

@article{Mohty1995AutologousHS,
  title={Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation},
  author={Mohamad Mohty and Kai H{\"u}bel and Nathan Kroeger and Mahmud Aljurf and Jane F. Apperley and Grzegorz W Basak and Ali Bazarbachi and K Douglas and Ian Gabriel and Laurent Garderet and Catarina Geraldes and Ozren Jak{\vs}i{\'c} and Michael W. Kattan and Zdeněk Koř{\'i}stek and Francesco Lanza and Roberto Massimo Lemoli and Larisa P Mendeleeva and Gabor Mikala and N M Mikhaĭlova and Arnon Nagler and Harry C. Schouten and Dominik L D Selleslag and Simona Suciu and Ana Sureda and Nina Worel and Patrick Wuchter and Christian Chabannon and R. Duarte},
  journal={Bone Marrow Transplantation},
  year={1995},
  volume={48},
  pages={S1-S37}
}
Autologous haematopoietic SCT with PBSCs is regularly used to restore BM function in patients with multiple myeloma or lymphoma after myeloablative chemotherapy. Twenty-eight experts from the European Group for Blood and Marrow Transplantation developed a position statement on the best approaches to mobilising PBSCs and on possibilities of optimising graft… CONTINUE READING